AAC
BSX icon

Asset Advisors Corp’s Boston Scientific BSX Stock Holding History

Asset Advisors Corp’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-200
Closed -$6K – 168
2017
Q2 		$6K Buy
+200
New +$5.31K ﹤0.01% 166
2017
Q1 		– Sell
-500
Closed -$11K – 179
2016
Q4 		$11K Buy
+500
New +$10.9K ﹤0.01% 154

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Asset Advisors Corp's BSX Position: Q3 2017 in Review

Asset Advisors Corp sold out of Boston Scientific (BSX) in Q3 2017, closing a stake of 200 shares — an estimated $6K sold.

Asset Advisors Corp first reported a position in BSX in Q4 2016 and held it in 2 quarters. The position peaked at $11K in Q4 2016. 547 funds tracked by Wall St. Rank hold BSX as of Q3 2017.

  • Asset Advisors Corp reported no remaining Boston Scientific position as of Q3 2017 after selling out during the quarter.
  • Asset Advisors Corp sold 200 Boston Scientific shares in Q3 2017, an estimated $6K.
  • Asset Advisors Corp first reported a position in Boston Scientific in Q4 2016 and held it in 2 quarters.
  • Asset Advisors Corp's Boston Scientific position peaked at $11K in Q4 2016.
  • 547 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2017.

Based on Asset Advisors Corp's 13F filing for Q3 2017, filed 19 Oct 2017.